Follow
John D. Clemens
John D. Clemens
icddr,b; ucla school of public health; international vaccine institute
Verified email at icddrb.org
Title
Cited by
Cited by
Year
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
KL Kotloff, JP Winickoff, B Ivanoff, JD Clemens, DL Swerdlow, ...
Bulletin of the World Health Organization 77 (8), 651, 1999
17841999
Vaccination greatly reduces disease, disability, death and inequity worldwide
FE Andre, R Booy, HL Bock, J Clemens, SK Datta, TJ John, BW Lee, ...
Bulletin of the World health organization 86, 140-146, 2008
14602008
The protective efficacy of polyvalent pneumococcal polysaccharide vaccine
ED Shapiro, AT Berg, R Austrian, D Schroeder, V Parcells, A Margolis, ...
New England Journal of Medicine 325 (21), 1453-1460, 1991
13721991
A study of typhoid fever in five Asian countries: disease burden and implications for controls
RL Ochiai, CJ Acosta, MC Danovaro-Holliday, D Baiqing, ...
Bulletin of the world health organization 86 (4), 260-268, 2008
9002008
Trial of calcium to prevent preeclampsia
RJ Levine, JC Hauth, LB Curet, BM Sibai, PM Catalano, CD Morris, ...
New England Journal of Medicine 337 (2), 69-77, 1997
8701997
Evidence for several waves of global transmission in the seventh cholera pandemic
A Mutreja, DW Kim, NR Thomson, TR Connor, JH Lee, S Kariuki, ...
Nature 477 (7365), 462-465, 2011
7922011
Looking beyond COVID-19 vaccine phase 3 trials
JH Kim, F Marks, JD Clemens
Nature medicine 27 (2), 205-211, 2021
6972021
The global burden of cholera
M Ali, AL Lopez, YA You, YE Kim, B Sah, B Maskery, J Clemens
Bulletin of the World Health Organization 90 (3), 209-218, 2012
6752012
Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up
JD Clemens, DA Sack, JR Harris, F Van Loon, J Chakraborty, F Ahmed, ...
The Lancet 335 (8684), 270-273, 1990
6141990
A Multicentre Study of Shigella Diarrhoea in Six Asian Countries: Disease Burden, Clinical Manifestations, and Microbiology
L Von Seidlein, DR Kim, M Ali, H Lee, XY Wang, VD Thiem, DG Canh, ...
PLoS medicine 3 (9), e353, 2006
6042006
Field trial of oral cholera vaccines in Bangladesh
JD Clemens, JR Harris, MR Khan, BA Kay, MD Yunus, AM Svennerholm, ...
The Lancet 328 (8499), 124-127, 1986
600*1986
Typhoid fever in children aged less than 5 years
A Sinha, S Sazawal, R Kumar, S Sood, VP Reddaiah, B Singh, M Rao, ...
The Lancet 354 (9180), 734-737, 1999
5471999
Helicobacter in the developing world
RW Frenck Jr, J Clemens
Microbes and infection 5 (8), 705-713, 2003
4792003
Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale …
JD Clemens, DA Sack, JR Harris, J Chakraborty, PK Neogy, B Stanton, ...
Journal of Infectious Diseases 158 (2), 372-377, 1988
3961988
The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study
KL Kotloff, WC Blackwelder, D Nasrin, JP Nataro, TH Farag, A Van Eijk, ...
Clinical infectious diseases 55 (suppl_4), S232-S245, 2012
3842012
Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis
M Ali, M Emch, L Von Seidlein, M Yunus, DA Sack, M Rao, J Holmgren, ...
The Lancet 366 (9479), 44-49, 2005
3642005
A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections
ED SHAPIRO, JD CLEMENS
Annals of internal medicine 101 (3), 325-330, 1984
3401984
Antimicrobial Drug Resistance of Salmonella enterica Serovar Typhi in Asia and Molecular Mechanism of Reduced Susceptibility to the Fluoroquinolones
TT Chau, JI Campbell, CM Galindo, N Van Minh Hoang, TS Diep, ...
Antimicrobial agents and chemotherapy 51 (12), 4315-4323, 2007
3252007
Effectiveness of mass oral cholera vaccination in Beira, Mozambique
MES Lucas, JL Deen, L Von Seidlein, XY Wang, J Ampuero, M Puri, M Ali, ...
New England Journal of Medicine 352 (8), 757-767, 2005
3232005
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness
S Ahmed, MM Karim, AG Ross, MS Hossain, JD Clemens, MK Sumiya, ...
International Journal of Infectious Diseases 103, 214-216, 2021
3182021
The system can't perform the operation now. Try again later.
Articles 1–20